Distinct biosignatures associate with survival after chemoimmunotherapy in a randomized, three-arm phase II study in patients with metastatic pancreatic cancer Meeting Abstract
| Authors: | Padrón, L. J.; Maurer, D. M.; O'Hara, M. H.; O'Reilly, E. M.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G. A.; Rahma, O. E.; Lyman, J. P.; Cabanski, C. R.; Yu, J.; Pfeiffer, S. M.; Spasic, M.; Hollmann, T. J.; Chen, R.; O'Donnell-Tormey, J.; Bucktrout, S.; LaVallee, T.; Vonderheide, R. H. |
| Abstract Title: | Distinct biosignatures associate with survival after chemoimmunotherapy in a randomized, three-arm phase II study in patients with metastatic pancreatic cancer |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301178 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4010 |
| Notes: | Meeting Abstract: 4010 -- Meeting also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
